Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.

Eitemau Tebyg

• Safety issues with bisphosphonate therapy for osteoporosis.
  gan: Suresh, E, et al.
  Cyhoeddwyd: (2014)
• Safety of bisphosphonates.
  gan: Pazianas, M, et al.
  Cyhoeddwyd: (2011)
• Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
  gan: Pazianas, M, et al.
  Cyhoeddwyd: (2010)
• Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
  gan: Pazianas, M, et al.
  Cyhoeddwyd: (2013)
• Eliminating the need for fasting with oral administration of bisphosphonates.
  gan: Pazianas, M, et al.
  Cyhoeddwyd: (2013)